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Abstract
Background: Improvements on malarial diagnostic methods are currently needed for the correct
detection in low-density Plasmodium falciparum infections. Microfluorimetric DNA-based assays
have been previously used for evaluation of anti-malarial drug efficacy on Plasmodium infected
erythrocytes. Several factors affecting the sensitivity of these methods have been evaluated, and
tested for the detection and quantification of the parasite in low parasitaemia conditions.
Methods: Parasitaemia was assessed by measuring SYBRGreen I® (SGI) and PicoGreen® (PG)
fluorescence of P. falciparum Dd2 cultures on human red blood cells. Different modifications of
standard methods were tested to improve the detection sensitivity. Calculation of IC50 for
chloroquine was used to validate the method.
Results:  Removal of haemoglobin from infected red-blood cells culture (IRBC) increased
considerably the fluorescent signal obtained from both SGI and PG. Detergents used for cell lysis
also showed to have an effect on the fluorescent signal. Upon depletion of haemoglobin and
detergents the fluorescence emission of SGI and PG increased, respectively, 10- and 60-fold,
extending notably the dynamic range of the assay. Under these conditions, a 20-fold higher PG vs.
SGI fluorescent signal was observed. The estimated limits of detection and quantification for the
PG haemoglobin/detergent-depleted method were 0.2% and 0.7% parasitaemia, respectively, which
allow the detection of ~10 parasites per microliter. The method was validated on whole blood-
infected samples, displaying similar results as those obtained using IRBC. Removal of white-blood
cells prior to the assay allowed to increase the accuracy of the measurement, by reducing the
relative uncertainty at the limit of detection from 0.5 to 0.1.
Conclusion:  The use of PG microassays on detergent-free, haemoglobin-depleted samples
appears as the best choice both for the detection of Plasmodium in low-density infections and anti-
malarial drugs tests.
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Background
The early detection and monitoring of malarial disease
has become a key requirement for the efficient control of
Plasmodium  infections. Asymptomatic individuals in
malaria-endemic areas may be infected at sub-micro-
scopic level and still produce gametocytes, contributing to
the transmission of the disease [1,2]. Detection of malaria
in pregnancy also poses a challenge due to the low parasi-
taemia in peripheral blood [3]. Malaria diagnosis has
relied on either thick blood film microscopy [4] or, more
recently, on circulating-antigen (CAg) [5] and PCR-based
methods [6-9]. While microscopic methods are simple,
they require trained microscopist and do not allow detec-
tion at densities below 50 parasites/μL. Real-time PCR
showed to be highly sensitive and allows the specific
detection of species, but it includes labour-consuming
methods such as DNA extraction, and requires expensive
equipment and temperature-labile consumables [10].
Highly-sensitive methods are also required for the in vitro
evaluation of new anti-malarial drugs, prompted by the
emergence and spread of parasite resistance [11]. The
need to evaluate the anti-malarial activity of new synthetic
or natural origin compounds against Plasmodium falci-
parum cultures demands highly sensible and reproducible
assays, making indispensable the optimization of existing
methods to obtain reliable dose-response curves and
adjust the doses of in vivo assays. Methods based on enzy-
matic [12] and radioactive labeled molecules [13] have
been used for detecting anti-plasmodial compounds, but
they are being progressively replaced by microfluorimetric
assays, based on the binding of the asymmetrical cyanine
dyes SGI [14-17] or PG [18-20] to DNA. These methods
allow evaluation of anti-malarial drug efficacy on erythro-
cyte cultures, by testing the arrest of the parasite DNA rep-
lication. These assays showed to be sensitive,
straightforward and rapid, allowing the screening of large
number of samples in 96-well format. Different authors
claimed the highest sensitivity for both SGI [17] and PG
[19] tests.
Both fluorescent dyes display significant structure homol-
ogies and have similar molar extinction coefficients, but
differ at the group attached to position 2 of the quinolin-
ium ring [21]: SGI has a N-(3-dimethylaminopropyl)-N-
propylamino and PG a N-bis-(3-dimethylaminopropyl)-
amino residue. The positive charges of PG and SGI are
likely contributing to the high binding affinity for dsDNA.
SGI carries two positive charges under standard condi-
tions, whereas PG carries three positive charges [21].
These molecules share the property of binding selectively
double-stranded DNA (dsDNA) by intercalation, result-
ing in an increase in fluorescence emission. Although PG
reagent is more sensitive for quantitating double-stranded
DNA (dsDNA) in solution [19], SGI is frequently used
due to its lower cost and higher safety [17].
As reported for PG [20], the use of fluorophores in blood-
cultures can be affected by haemoglobin quenching of the
fluorescent signal. Due to the wide absorption spectrum
of haemoglobin, between 300-800 nm, this molecule
could interfere not only with the fluorescence emitted by
PG (excitation/emission 390/505 nm) but also with SGI
(505/615 nm). In addition, the presence of detergents in
the composition of lysis/fluorescent solutions have been
reported to have an effect on the detection of DNA with
PG [20].
The use of SGI or PG microfluorimetric assays for the
detection of Plasmodium in clinical isolates may be ham-
pered by the presence of nucleated blood cells in the sam-
p l e .  A i m i n g  t o  f i n d  a n  o p t i m i z e d  a s s a y  a l l o w i n g  t h e
highest sensitivity for the detection and quantification of
Plasmodium DNA in erythrocytes, usable for monitoring
both low-parasitaemia malaria in clinical samples and the
screening of anti-malarial drugs, a systematic analysis was
carried out to asses the effect of detergents, haemoglobin
and the presence of white-blood cells in the assay. Hence,
a PG-based method is proposed, suitable for detection
and quantification of Plasmodium in blood and reaching
sensitivity near to that reported for PCR-based methods
Methods
DNA standard curves in the presence of detergents
SYBRGreen I®  (S33102) and PicoGreen® (P7589) were
purchased to Invitrogen and diluted as indicated by the
manufacturer in TE buffer (10 mM Tris-HCl, 1 mM EDTA,
pH 7.5) or TE plus different combinations of saponin and
Triton X-100 detergents to obtain a range of concentra-
tions from 1000 ng/mL to 5 ng/mL. Standard curves of
DNA were performed by diluting bacteriophage λ DNA,
provided at 100 μg/mL in the Quant-iT™ PicoGreen® Kits
(Molecular Probes™, Invitrogen) with DNase-free water.
One hundred microliters of each mixture were dispensed
into black 96-well microplate (Costar®), followed by the
addition of 100 μl of either PG or SGI. Plates were incu-
bated in the dark at room temperature for 5 minutes and
the fluorescence intensity was measured at 485 nm excita-
tion and 528 nm emission using a Perkin Elmer LS-50B
Luminescence Spectrophotometer. The mean background
reading from the two control wells was subtracted from
the test reading to give the final fluorescence measure-
ment. Fluorescence units (arbitrary units ranging from 1
to 1,000 units) was plotted against DNA concentration.
Haemoglobin effect on fluorescent measurements
Fluorescence measurements in the presence of haemo-
globin was carried out by washing uninfected human
blood in RPMI1640 medium (final 50% haematocrit)Malaria Journal 2009, 8:279 http://www.malariajournal.com/content/8/1/279
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and treated with Lymphoprep™ (AXIS-SHIELD) as indi-
cated by manufacturer to remove most of the WBC (white
blood cells). Erythrocytes were resuspended in culture
medium [22] to get a haematocrit of 1-5%, and lysed by
freeze-thawing. Each sample was spiked with lambda
DNA at a final concentration of 1 μg/mL. 100 μL of each
mixture were added to 100 μL of either SGI or PG and the
fluorescence signal was determined as described above. In
addition, the absorption spectrum from red blood cells
lysates was evaluated. All measurements were performed
in triplicate from three processed samples independently
Stock culture of P. falciparum
Chloroquine resistant strain Dd2 of P. falciparum (clone
MRA-150, [23] was used for this study. The strain was cul-
tivated in vitro as described previously [22]. The culture
media consisted of standard RPMI 1640 (Sigma-Aldrich)
supplemented with 0.5% ALBUMAX I (Gibco), 100 μM
hypoxanthine (Sigma-Aldrich), 25 mM HEPES (Sigma-
Aldrich), 12.5 μg/mL gentamicine (Sigma-Aldrich) and
25 mM NaHCO3  (Sigma-Aldrich). Erythrocytes were
obtained from type A+ human healthy local donors and
collected in tubes with citrate-phosphate-dextrose antico-
agulant (VACUETTE®), and washed as described above.
Each culture was started by mixing uninfected and
infected erythrocytes to achieve a haematocrit at 1% and
incubated in 5% CO2 at 37°C in tissue culture flasks
(Iwaki). The progress of growth in the culture was deter-
mined by microscopic counting of parasitaemia in thin
blood smears with Wright's eosin methylene blue solu-
tion (Merck) using the freely available "Plasmoscore" soft-
ware [24]. The cultures were synchronized by incubation
with sorbitol as described [25].
Determination of IC50
Synchronized rings from stock cultures were used to test 5
μM to 1 nM serial dilutions of chloroquine in 96-well cul-
ture microplates. Thus, 150 μL of parasites at 2% haemat-
ocrit and 1% parasitaemia were allowed to grow for 48-
hour in 5% CO2 at 37°C. Parasites were then centrifuged
at 600 × g for 10 minutes and the re-suspended in saponin
to lyse the erythrocytes. The pellet was washed to remove
haemoglobin as described [20]: 150 μL of each sample
were dispensed in 96-well microplates, which were centri-
fuged at 600 × g for 10 minutes. The supernatant was
removed and the cells were re-suspended in saponin
(0.15%, w/v in phosphate-buffered saline (PBS) to lyse
the erythrocytes and release the malaria parasites. The
microplates were immediately centrifuged at 600 × g for
10 minutes, and the supernatant was removed. To elimi-
nate all traces of haemoglobin the pellet was washed by
the addition of 200 μL of PBS followed by centrifugation
at 600 × g. The washing step was repeated twice to ensure
complete removal of haemoglobin. Finally, pellets were
re-suspended in 100 μL of PBS. 100 μL of either PG or SGI
diluted in TE were added to each well. Then, the plates
were incubated for 30-60 minutes in the dark. The fluores-
cence signal was determined as described above. Fluores-
cence Unit (AU) was calculated by subtracting the control
negative (fluorescence from uninfected erythrocytes) [13].
AU was converted to percentage (%) of survival in the
fluorimetric drug susceptibility test by the following equa-
tion:
Where, Fd is the fluorescence from drug treated infected
erythrocytes, Fcp is the fluorescence control positive: fluo-
rescence from non-treated infected erythrocytes, and Fcn
is fluorescence control negative: fluorescence from unin-
fected erythrocytes. The logarithm of the chloroquine con-
centration was plotted against the corresponding
percentage (%) of survival, and the 50% inhibitory con-
centration (IC50) was calculated by non-linear regression.
All measurements were performed in triplicate from two
processed samples independently. The curve fitting was
performed using Sigmaplot©10 from Systat Software, Inc.
Correlation of parasitaemia and fluorescence
A serial dilution of the synchronized cultures of P. falci-
parum (mature ring stage) was performed with non-para-
sitized erythrocytes and complete medium to yield a
haematocrit of 2% and parasitaemia levels ranging from
0.05% to 15%. Haemoglobin-depleted samples were
obtained as indicated above. In these assays, 100 μL of
either SGI or PG were added to each microplate well and
the fluorescence signal was determined. To analyse the
effect of TritonX-100, a set of haemoglobin-depleted sam-
ples were mixed with SGI or PG plus TritonX-100 (2% v:v
final concentration). Control samples without haemo-
globin removal were analysed in parallel. In this case, the
parasitized erythrocytes were lysed by using the lysis/fluo-
rescence-mix, consisting of either SGI, 0.008% saponin
and 0.08% Triton X-100, or PG with 2% Triton X-100.
Fluorescence readings were plotted against parasitaemia.
Assays on whole blood were carried out by diluting a sorb-
itol-synchronized culture with a donor peripheral blood
to achieve different levels of parasitaemia from 15% to
0.05%. Two series of dilutions were performed: the first
series was prepared at 50% haematocrit and 400 μL were
added to 200 μL Lymphoprep™ to remove WBC. The
resulting sediment was washed and diluted with phos-
phate buffered saline to obtain 2% final haematocrit. The
second series was directly diluted to 2% haematocrit with-
out WBC removal. Haemoglobin was depleted both from
Lymphoprep-treated and non-treated samples, and PG-
DNA fluorescence was determined as above.
Survival
Fd Fcn
Fcp Fcn
=
−
−
×
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All measurements were performed in triplicate from three
processed samples independently. The relative uncer-
tainty (relative error) was calculated as the standard devi-
ation divided by the mean. The limit of detection (LOD)
was established as the lowest parasitaemia yielding fluo-
rescent signal significantly different from the blank con-
trol. The limits quantification (LOQ) corresponds to the
lowest parasitaemia that can be quantified with accepta-
ble accuracy and precision. LOD and LOQ were calculated
as indicated by the International Conference on Harmo-
nization (ICH) guidelines [26] by using:
Where sB is the standard deviation of the blank sample, m
is the slope of the calibration curve and t = 3.3 is the Stu-
dent's t for a 95% confidence level. Statistics and curve fit-
ting was performed using Sigmaplot©10 from Systat
Software, Inc.
Results
Effect of detergents on SGI and PG DNA measurements
Several fluorimetric-based protocols make use of different
combinations of saponin and TritonX-100 as detergents
for the combined erythrocyte lysis/fluorescence detection
in parasitaemia measurements. To ascertain the effect of
these detergents in SGI and PG assays, DNA standard
curves were prepared in the presence of different deter-
gents currently used in lysis/fluorescent mixes. The results
showed a direct relationship between DNA concentration
and fluorescence (Figure 1). Higher signal was detected
for PG (706 ± 33 AU per 1 μg/mL) as compared to SGI
(141 ± 40 AU per 1 μg/mL) in TE. The presence of deter-
gents changed the slope of the standard curves for both
dyes. All combinations tested generated a decrease in the
fluorescent signal, with the exception of PG 2% Triton X-
100 which displayed a slight increment. The mixture of
0.008% saponin and 0.08% Triton X-100 appears to have
a smaller effect of both dyes (<10% in SGI, <2.5% for PG),
while these detergents added separately showed interme-
diate results.
Effect of haemoglobin on fluorescence
The effect of haemoglobin on fluorescent readings was
tested by mixing different amounts of lysed erythrocytes
(1-5% haematocrit) with a fixed amount of λ DNA. Eryth-
rocytes were lysed by freeze-thawing to avoid the use of
detergents which, as shown above, might interfere with
the fluorescence measurements.
The fluorescence emission of both SGI- and PG-DNA
adducts, shown in Figure 2A, was highly quenched in
presence of red cells. Control samples, containing DNA
without haemoglobin, rendered fluorescence readings
around 30-60 fold as compared with samples containing
blood, suggesting a heavy interference of haemoglobin.
Detection of fluorescence in presence of blood, even at the
LOD
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DNA titration using SYBR®Green I and PicoGreen® dyes Figure 1
DNA titration using SYBR®Green I and PicoGreen® dyes. PicoGreen® fluorescence (A) and SYBR®Green I fluores-
cence (B) with bacteriophage λ DNA in absence (black circle, solid line), or presence (dotted lines) of different amounts of 
detergents: saponin 0.008% + Triton X-100 0.08% (white triangle); saponin 0.008% (white square); Triton X-100 0.08% (white 
diamonds); Triton X-100 2% (white circle). Background fluorescence, defined as fluorescence detected in the absence of DNA, 
was subtracted from each data point. Fluorescence is measured as arbitrary units (AU). Data show average from three repli-
cate experiments. Error bars indicate standard deviations. Lines were calculated by linear regression; r2 >0.99.
B
0
20
40
60
80
100
120
140
160
0 200 400 600 800 1000
DNA (ng/mL)
F
l
u
o
r
e
s
c
e
n
c
e
 
(
A
U
)
A
0
100
200
300
400
500
600
700
800
900
0 200 400 600 800 1000
DNA (ng/mL)
F
l
u
o
r
e
s
c
e
n
c
e
 
(
A
U
)Malaria Journal 2009, 8:279 http://www.malariajournal.com/content/8/1/279
Page 5 of 10
(page number not for citation purposes)
Effect of haemoglobin on fluorescence emission Figure 2
Effect of haemoglobin on fluorescence emission. A) Fluorescence emission of SYBR®Green I (solid bars) and 
PicoGreen® (empty bars) of 1 μg/mL DNA, (485/2.5 nm excitation, 528/2.5 nm emission) in the presence of different amounts 
of red blood cells. The inset shows the fluorescence signal at 485/15 nm excitation and 528/15 nm emission. Discontinuous 
bars indicate off-scale fluorescent reading. Fluorescence at 0% haematocrit was obtained from a 1 μg/mL solution of λDNA in 
culture medium. B) Absorption spectrum of red blood cell lysates.
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Chloroquine dose-response curve Figure 3
Chloroquine dose-response curve. Chloroquine responses of P. falciparum in erythrocyte cultures obtained using PG (A) 
and SGI (B), after removal of haemoglobin/detergents. Sigmoid graphs show the survival of P. falciparum Dd2 at different con-
centrations of drug. Bars indicate the standard errors of the mean for two independently processed samples. The calculated 
IC50 values were 136.2 ± 28 nM for PG and 118 ± 15 nM for SGI.
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lowest content, was only possible by opening the optical
slit of the detector to 15 nm. Under these conditions the
fluorescence emission from 1 μg/mL DNA samples in 0%
haematocrit was rendered off scale.
As shown in Figure 2B the absorption spectrum of red
blood cell lysates revealed the existence of two peaks of
maxima absorption at 485 nm and 529 nm, which over-
lap with the excitation/emission wavelengths of SGI and
PG, and may therefore explain the quenching of haemo-
globin on the fluorescent readings.
Calculation of IC50 for chloroquine
To test if the signal increase observed after depletion of
haemoglobin may lead to changes in the calculated IC50
values of current anti-malarial drugs, dose-response
curves for chloroquine were obtained using either PG or
SGI. No significant differences in the IC50 values were
observed for chloroquine in fluorimetric anti-malarial
drug assays run in parallel (p > 0.05) (Figure 3). The IC50
for chloroquine against strain Dd2 of P. falciparum was
136.2 ± 28 nM when using PG and 118 ± 15 nM for SGI.
These values were similar to those reported by other
authors using different techniques [15,27,28]. Chloro-
quine is a known DNA intercalating agent [29,30], and it
has been shown that it may lead to 23% PG exclusion in
the range of 0.5 to 1 mM [31]. The possible effect of the
drug on the binding of the fluorescent dye to DNA at con-
centrations used in the IC50 assay was tested by compari-
son of the DNA-PG calibration curves in the presence of
chloroquine at 1 μM and 5 μM. No significant differences
in the slope or intercept were observed as compared to the
control curve without drug (p > 0.05, data not shown),
suggesting that chloroquine do not interfere with PG
binding to DNA well above the highest concentration
used.
Fluorescent signal as measurement of Plasmodium 
parasitaemia
As shown above, the choice of DNA-fluorescent dye and
the removal of haemoglobin before fluorescent readings
may enhance the sensitivity of the assay. In addition, the
presence of 2% Triton X-100 showed an increase in the
fluorescent signal of PG-DNA adducts, while other deter-
gent formulations may reduce that signal (Figure 1). To
analyse the effect of haemoglobin depletion and the addi-
tion of 2% Triton X-100 on the quantification of Plasmo-
dium parasitaemia, the fluorescence obtained in cultures
with or without haemoglobin removal was compared.
While samples containing haemoglobin were lysed by
adding a fluorescent mix containing detergents, haemo-
globin-depleted samples were first lysed with saponin,
washed and resuspended in PBS, and the fluorescent mix
was added without detergents, avoiding thus any interfer-
ence due to these compounds. The effect of Triton X-100
was tested only on haemoglobin-depleted samples, by
mixing PG or SGI with TritonX-100 2%.
The results, shown in the Figure 4, confirm the linear cor-
relation between the percentage of infected red blood cells
and the fluorescence. As expected, PG exhibited much
higher fluorescence emission than SGI (20-fold at 15%
Correlation between parasitaemia and fluorescence emission Figure 4
Correlation between parasitaemia and fluorescence emission. PG (A) and SGI (B) fluorescence detected in Plasmo-
dium falciparum infected erythrocytes at different parasitaemias. A serial fold dilution of synchronized infected culture (15% 
mature ring stage) with non-infected erythrocytes was used. Results are shown for haemoglobin non-depleted samples (black 
square), and haemoglobin depleted samples in the absence (white square) or presence (white circle) of 2% Triton X-100. Bars 
indicate the standard deviation of the mean from three independently processed samples.
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parasitaemia). SGI results showed a higher interference of
TritonX-100 by decreasing both the slope (2.2 versus 1.4
AU/%parasitaemia) and the correlation of the linear
response (r2 > 0.99 to r2 > 0.97). Best results were obtained
with PG in samples devoid of haemoglobin (r2 > 0.99, m
= 46.6): for a 15% parasitaemia culture, fluorescent read-
ings were in the range of 650-700 vs. 11 (arbitrary fluores-
cence units) in non-depleted haemoglobin. The presence
of 2% TritonX-100 showed a much smaller effect, with no
clear gain or loss on the signal.
The fluorescence of highly diluted samples of a P. falci-
parum culture using SGI or PG under these conditions (no
haemoglobin, no detergent) is shown in Table 1. While
SGI was not able to detect a parasite load below 0.6%, PG
yielded fluorescent readings down to 0.05% and showed
a 7-fold higher signal than SGI at 0.6% parasitaemia, lead-
ing to a similar reduction of the calculated LOD from
1.4% to 0.2%. Similarly, a 6-fold reduction of the LOQ
was observed when using PG as compared to SGI.
Once established the PG haemoglobin/detergent-
depleted method as the most appropriate for low-parasi-
taemia samples, its capability for detection and quantifi-
cation of Plasmodium in whole blood samples, as those
coming from clinical isolates, was tested. A synchronized
P. falciparum culture was diluted with human peripheral
blood to obtain parasitaemia ranging from 15% to 0.05%
(IRBC+WBC samples). Each dilution was split in two and
one of them was treated with Lymphoprep™ to remove
WBC (IRBC+WBC/W). Haemoglobin was depleted from
both samples and fluorescence was measured with PG.
The results showed a good correlation of fluorescence ver-
sus parasitaemia (r2 > 0.99) in both conditions. Data at
parasitaemia in the range of 5% to 0.05% are shown in the
Table 1, indicated that the method can detect down to
0.2% parasitaemia even in the presence of WBC DNA,
although the high variability observed in these samples
may compromise the accuracy of results. To solve this
problem, an additional wash step was included in the pro-
tocol to remove WBC prior to the fluorescent reading. The
Figure 5 shows a comparison of the relative uncertainty of
the measurements obtained from IRBC, IRBC+WBC and
IRBC+WBC/W samples at low parasitaemia. While the rel-
ative uncertainties were very low (<0.15) for parasitae-
mias >1.5% in all samples, only IRBC and IRBC+WBC/W
samples showed relative uncertainties <0.3 at the LOD
and LOQ values: Removal of WBC reduced the relative
error from 0.5 to 0.12 at 0.2% parasitaemia, and from 0.2
to 0.04 at 0.6% parasitaemia. These results suggest that
white cell removal should be performed to achieve the
highest accuracy at the LOD and LOQ range.
The possibility of increasing the sensitivity by using higher
haematocrit was also explored by measuring fluorescence
from IRBC+WBC/W samples at 5% and 10% haematocrit.
The results (not shown) displayed a non-linear correla-
tion of fluorescence to parasitaemia, which could be asso-
ciated to the accumulation of cell-debris after lysis
interfering with the fluorescence measurement.
Discussion
Monitoring pathogen DNA by fluorimetric methods
appears to be a suitable technique for the determination
of parasitaemia in infected cells. The system may be par-
ticularly effective for the high-throughput screening of
Table 1: Fluorescence of PG and SGI - DNA adducts on Plasmodium infected erythrocytes at low parasitaemia after removal of 
haemoglobin and detergents
Fluorescence units (AU)
SYBRGreen I® PicoGreen®
% parasitaemia IRBC IRBC IRBC-WBC IRBC-WBC/W
5 15 ± 3 229 ± 12 243 ± 4 279 ± 8
2.5 9 ± 2 127 ± 7 141 ± 8 161 ± 7
1.3 6 ± 2 52 ± 1 83 ± 9 80 ± 4
0.6 5 ± 4 36 ± 3 36 ± 11 45 ± 2
0.3 ND1 20 ± 5 20 ± 8 31 ± 4
0.1 ND 11 ± 3 11 ± 3 14 ± 2
0.05 ND 5 ± 4 ND 7 ± 3
Limits of detection and quantification (parasitaemia %)
LOD 1.37 0.23 0.21 0.24
LOQ 4.14 0.71 0.74 0.64
IRBC = Infected red-blood cells; IRBC-WBC = Infected red-blood cells whithout white blood cells removal; IRBC-WBC/W = Infected red-blood 
cells after white blood cells removal; ND = not detected.Malaria Journal 2009, 8:279 http://www.malariajournal.com/content/8/1/279
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potential anti-parasitic drugs, as their effect on the arrest
of pathogen DNA replication can be easily detected and
quantified. These methods depend largely on the sensitiv-
ity and dynamic range of the fluorescent emission
obtained with DNA intercalating agents. Highly sensitive
fluorescent dyes should allow the use of small culture vol-
umes, the monitoring of low parasitaemias and the high-
throughput assays of anti-malarial drugs. In this study it is
shown that PG is 5-fold more sensitive than SGI on puri-
fied DNA samples. Haemoglobin has been reported to
drastically quench the fluorescent signal of DNA-PG
adducts [20], while other authors do not observed signif-
icant effects of haemoglobin under the same conditions
[19]. In this work, such interference has been quantified,
showing that in DNA/lysed red blood cell mixtures (2%
haematocrit), the fluorescent signal was quenched to 1%
(PG) or 2% (SGI) of the purified DNA reading. The
absorption spectrum of haemoglobin shows two peaks at
485 and 529 nm which overlap almost exactly the excita-
tion/emission wavelengths for SGI [17,21] and PG [32].
Detergents are used routinely in the preparation of lysis/
fluorescent mixes in fluorimetric method for detection of
anti-malarial drugs [17,19,20]. The use of diluted deter-
gents may facilitate the adequate dye-nucleic acid interac-
tion and detection of fluorescence. However, different
results have been reported on the effect of detergents:
while PG appeared not to be affected by TritonX-100 up
to 2% [20], lower fluorescent signal was detected in SGI
on 0.08% TritonX-100 [17]. The results showed in this
work suggest that, in general, the presence of Triton X-100
and other detergents decrease the fluorescent signal of
both dye-DNA adducts. Although the presence of 2% Tri-
tonX-100 increases slightly the fluorescence of PG on λ
DNA, no clear differences were observed on cultures of
Plasmodium in erythrocytes. Consequently, and as a gen-
eral guideline, it would be desirable to remove all deter-
gents prior to the measurement of fluorescence.
In order to both remove haemoglobin and prevent the
presence of detergents in the fluorimetric assay, Plasmo-
dium  infected erythrocytes were disrupted by using
saponin, followed by several washes for removing haemo-
globin and detergent, and no additional detergents were
used in the fluorescent dye solutions. Using this
approach, 10-fold and 60-fold increases in sensitivity
were obtained for SGI and PG respectively. In addition,
and differently from other methods published, the pro-
posed protocol was performed in a single 96-well micro-
plate, allowing both parasite cultivation and fluorescent
reading in the same plate, circumventing any culture
transfer which may increase the variability of results. As
shown in this work, the calculation of IC50  was not
affected by the choice of DNA fluorescent dye or the pres-
ence of haemoglobin/detergents in the sample, suggesting
that low sensitivity is not critical for estimation of the con-
centration yielding a 50% parasite survival. However, the
optimization of the microfluorimetric method to increase
sensitivity should be critical for other applications where
microscopic methods are not effective, such as the moni-
toring of sub-microscopic infections the early stages of
disease or in pregnancy and estimation the efficiency of
vaccines. Microfluorimetric methods had not been tested
previously on whole blood samples. Here, it is shown that
a PG haemoglobin/detergent-depleted microfluorimetric
assay allows to decrease the LOD to 0.2% parasitaemia on
whole blood samples. The relative high dispersion of the
fluorescence readings observed at this parasitaemia was
reduced by adding a WBC wash prior to the haemoglobin
removal. This additional step can be easily performed by
any WBC removal protocol adapted to microplate format.
Although Lymphoprep was used here for WBC removal,
other methods are currently available and could be used
for elimination of non-erythrocytic cells. In a recent
report, a CF11 cellulose filter was shown to be particularly
efficient for removal of leukocyte and platelet cells from
whole blood [33]. The use of this method could further
improve the sensitivity of the assay in clinical samples.
Relative uncertainty of fluorescent measurements of PG- DNA adducts in low parasitaemia samples Figure 5
Relative uncertainty of fluorescent measurements of 
PG-DNA adducts in low parasitaemia samples. Plot of 
the relative uncertainty calculated form the fluorescence 
readings at different parasitaemias shown in the Table 1. 
Results are displayed for infected red-cell cultures (IRBC, 
black square, dashed line), infected red-cell cultures diluted 
with peripheral blood (IRBC+WBC, white circle, solid line), 
and infected red-cell cultures diluted with peripheral blood 
and depleted of white-cells (IRBC+WBC/W, white square, 
dotted line). All samples were processed for removal of hae-
moglobin and detergents. Curves fitted using inverse first 
order polynomial equation, r2> 0.97.
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The 0.2% parasitaemia LOD established for this protocol
corresponds to 10 parasites per μL. Thick blood film
examination by an experienced microscopist should
detect 50 parasites/μL [5], although routine laboratory
diagnosis achieves a much lower sensitivity of ~500 para-
sites/μL [34]. Nested-PCR techniques have been reported
to achieve <10 parasites/μL [35]. Quantitative real-time
PCR may reach even lower thresholds ranging from 0.3 to
3 parasites/μL depending on the Plasmodium species [36].
High rates of sensitivity and specificity have been reported
for real-time PCR on clinical isolates [10]. PCR methods
have, however, their own limitations, as amplicon num-
bers may not reflect the number of parasitized cells: the
presence of multiple copies of the target DNA, multinucle-
ate schizonts, and DNA released from lysing cells may
cause overestimation of the actual parasitaemia [37,38].
Relative high-cost and the need to operate in environ-
ments maintaining a cold chain also hinders the use of
these methods in most malaria endemic areas. Due to
these limitations, the use of more than one established
molecular method as gold standard to assess novel
malaria diagnostic kits has been proposed [10].
While the proposed protocol allows to diagnose the pres-
ence of the parasite in infections at 0.2% parasitaemia,
quantitative results can be accurately obtained from 0.6%
parasitaemia samples. This capability can be useful for the
monitoring of residual infections or for the screening of
new anti-malarial compounds.
This comparative study has shown that uncomplicated
methodological improvements of fluorimetric tests, such
as haemoglobin and detergent depletion on PG-based
assays, can enhance their sensitivity to be comparable to
that obtained by other molecular methods, preserving the
low work load and quickness intrinsic to these methodol-
ogies. The additional removal of WBC extends the useful-
ness of the modified fluorimetric method to the diagnosis
and monitoring of Plasmodium infections in clinical appli-
cations. This assay might be easily standardized and auto-
mated for large-scale analysis, facilitating monitoring of
low parasitaemias in infected red-cells, as well as for in
vitro screening of anti-malarial drugs.
Conclusion
A modified PicoGreen microfluorimetric method allows
to reach sensitivity on parasitaemia assays similar to those
obtained with PCR-based methods. The proposed
approach would be best suitable for epidemiological stud-
ies allowing parasite detection on sub-microscopic and/or
asymptomatic infections in endemic countries, as well as
for large-scale trials on new anti-malarial drugs.
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